Tumor cell vaccines

Pantel, K., A. Dickmanns, A. Zippelius, C. Klein, J. Shi, W. Hoechtlen-Vollmar, G. Schlimok, D. Weckermann, R. Oberneder, E. Fanning, and et al. 1995. Establishment of micrometastatic carcinoma cell lines A novel source of tumor cell vaccines. J Natl Cancer Inst 87(15) 1162-8. 

Hogge, G.S., Burkholder, J., Culp, J., Dubielzig, R.R., Albertini, M.R., Keller, E.T. et al. (1998) Development of human granulocyte macrophage-colony stimulating factor transfected tumor cell vaccines for the treatment of spontaneous canine cancer. Hum. Gene Ther., 9, 1851-1861. 

Liebtich, W., Schlag, R, Manasterski, M., Lehner, B., Stohr, M., Moller, R. and Schirrmacher, V. (1991). In vitro and clinical characterisation of a Newcastle disease virus-modified autologous tumor cell vaccine for treatment of colorectal cancer patients. Eur. J. Cancer 27, 703-710. 

LaTemple, D. C., Henion, T. R., Anaraki. F., and Galili, U., Synthesis of alpha-galactosyl epitopes by recombinant alphal, 3galactosyl transferase for opsonization of human tumor cell vaccines by anti-galactose, Cancer Res., 6, 3069, 1996. 

Antonia, S.J. (1999) B7-1 gene-modified tumor cell vaccines. Curr Opin Mol Ther 1 50-56. 

Nanni P, Nicoletti G, De Giovanni C, Landuzzi L, Di Carlo E, Cavallo F, Pupa SM, Rossi I, Colombo MP, Ricci C, Astolfi A, Musiani P, Forni G, Lollini PL Combined allogeneic tumor cell vaccination and systemic interleukin 12 prevents mammary carcinogenesis in HER-2/neu transgenic mice. J Exp Med 2001 194 1195-1205. 

Nemunaitis J et al. Phase II study of belagenpumatucel-L, a transforming growth factor beta-2 antisense gene-modified allogeneic tumor cell vaccine in non-small-cell lung cancer. J Clin Oncol 2006 24 4721 730. 

Fakhrai H, Mantil JC, Liu L, Nicholson GL, Murphy-Satter CS, Ruppert J et al. Phase I chnical trial of a TGF-beta antisense-modified tumor cell vaccine in patients with advanced ghoma. Cancer Gene Ther 2006 13 1052-1060. 

Andersen BH, Ohlfest JAR. Increasing the efficacy of tumor cell vaccines by enhancing cross priming. Cancer Lett. 2012 325 155-64. 

Goldstein, M.J., Varghese, B., Brody, J.D., Rajapaksa, R., Kohrt, H., Czerwinski, D.K., Levy, S., Levy, R. A CpG-loaded tumor cell vaccine induces antitumor CD4 -I- T cells that are effective in adoptive therapy for large and established tumors. Blood 117, 118-127 (2011)... 

Rousseau, R. F., Haight, A. E., Hirschmaim-Jax, C., Yvon, E. S., Rill, D. R., Mel, Z., Smith, S. C., Inman, S., Cooper, K., Alcoser, P., Grilley, B., Gee, Popek, E., Davidoff, A., Bowman, L. C., Brenner, M. K., and Strother, D. (2003). Local and systematic effects of an allogeneic tumor cell vaccine combining transgenic human lymphotactin with interleukin-2 in patients with advanced or refractory neuroblastoma. Blood 101, 1718-1726. 

Asada H, Kishida T, Hirai H, Satoh E, Ohashi S, Takeuchi M, et al (2002) Significant antitumor effects obtained by autologous tumor cell vaccine engineered to secrete interleukin (IL)-12 and IL-18 by means of the EBV/lipoplex. Mol Ther 5 609-616... 

Moret-Tatay I, Diaz J, Marco FM, Crespo A, Alino SF (2003) Complete tumor prevention by engineered tumor cell vaccines employing nonviral vectors. Cancer Gene Ther 10 887-897... 

Tumor Cell Vaccines Cytokine Gene Therapy for Lung Cancer... 

---